侵袭性肺曲霉菌病(IPA)常发生于重度免疫损害患者中,发生在免疫功能完全正常宿主中较少见。一旦发生患者病情重,进展迅速,未经治疗者几乎100%死亡,因患者无常见的高危因素,临床上常被误诊[1]。现报道我院经伏立康唑成功治疗的2例原发性IPA,以提高临床警惕性。1病历资料例1.女,2 Invasive pulmonary aspergillosis (IPA) often occurs in severe immunocompromised patients, occurring less frequently in fully normal immune function hosts. In the event of severe illness and rapid progression, almost 100% of those who die without treatment are often clinically misdiagnosed due to the lack of common high-risk factors. Now reported in our hospital Voriconazole successful treatment of 2 cases of primary IPA, to enhance clinical vigilance. 1 case record data 1. Female, 2